Profilo
Glenn A. Hopkins is currently a Director at RHEI Pharmaceuticals, Inc. Prior to his current position, he worked as a Principal at Thomas H.
Lee Partners LP from 1989 to 1994 and as a Partner at Prospect Hill Growth Partners LP from 1995 to 2014.
Hopkins received his undergraduate and graduate degrees from the Massachusetts Institute of Technology.
Posizioni attive di Glenn A. Hopkins
| Società | Posizione | Inizio |
|---|---|---|
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, licenses, develops and commercializes therapies | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Glenn A. Hopkins
| Società | Posizione | Fine |
|---|---|---|
Thomas H. Lee Partners LP
Thomas H. Lee Partners LP Investment ManagersFinance Thomas H Lee Partners invests in middle market companies located in the United States. The firm targets companies operating in the fields of financial technology & services, healthcare, technology & business solutions and automation sectors. It provides financing for growth, acquisitions, recapitalizations and buyout stage capital transactions. | Corporate Officer/Principal | 31/12/1994 |
Prospect Hill Growth Partners LP
Prospect Hill Growth Partners LP Investment ManagersFinance Prospect Hill Growth Partners invests in middle-market growth companies located in North America with revenues of USD 50 - 300 million and EBITDA of USD 5 - 25 million. The firm focuses on the consumer and healthcare strategy sectors. It participates in buyout transactions with an investment size of USD 25 - 100 million. It also makes co-investments. | Corporate Officer/Principal | - |
Formazione di Glenn A. Hopkins
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Thomas H. Lee Partners LP
Thomas H. Lee Partners LP Investment ManagersFinance Thomas H Lee Partners invests in middle market companies located in the United States. The firm targets companies operating in the fields of financial technology & services, healthcare, technology & business solutions and automation sectors. It provides financing for growth, acquisitions, recapitalizations and buyout stage capital transactions. | Finance |
Prospect Hill Growth Partners LP
Prospect Hill Growth Partners LP Investment ManagersFinance Prospect Hill Growth Partners invests in middle-market growth companies located in North America with revenues of USD 50 - 300 million and EBITDA of USD 5 - 25 million. The firm focuses on the consumer and healthcare strategy sectors. It participates in buyout transactions with an investment size of USD 25 - 100 million. It also makes co-investments. | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, licenses, develops and commercializes therapies | Health Technology |
















